KR20090035581A - 신장 기능 장해 예방ㆍ치료제 - Google Patents

신장 기능 장해 예방ㆍ치료제 Download PDF

Info

Publication number
KR20090035581A
KR20090035581A KR1020097002253A KR20097002253A KR20090035581A KR 20090035581 A KR20090035581 A KR 20090035581A KR 1020097002253 A KR1020097002253 A KR 1020097002253A KR 20097002253 A KR20097002253 A KR 20097002253A KR 20090035581 A KR20090035581 A KR 20090035581A
Authority
KR
South Korea
Prior art keywords
silnidipine
valsartan
angiotensin
agent
preventing
Prior art date
Application number
KR1020097002253A
Other languages
English (en)
Korean (ko)
Inventor
시즈카 아리토미
도모유키 곤다
아키라 미쓰이
히로타카 와가쓰마
Original Assignee
아지노모토 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아지노모토 가부시키가이샤 filed Critical 아지노모토 가부시키가이샤
Publication of KR20090035581A publication Critical patent/KR20090035581A/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020097002253A 2006-08-04 2007-08-06 신장 기능 장해 예방ㆍ치료제 KR20090035581A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006213714 2006-08-04
JPJP-P-2006-213714 2006-08-04

Publications (1)

Publication Number Publication Date
KR20090035581A true KR20090035581A (ko) 2009-04-09

Family

ID=38997341

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097002253A KR20090035581A (ko) 2006-08-04 2007-08-06 신장 기능 장해 예방ㆍ치료제

Country Status (4)

Country Link
JP (1) JPWO2008016171A1 (fr)
KR (1) KR20090035581A (fr)
CN (1) CN101522194B (fr)
WO (1) WO2008016171A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013147137A1 (fr) * 2012-03-30 2013-10-03 味の素株式会社 Agent thérapeutique pour le traitement de l'insuffisance cardiaque
KR101778050B1 (ko) * 2012-10-12 2017-09-13 이에이 파마 가부시키가이샤 칼슘 길항약／안지오텐신 ｉｉ 수용체 길항약 함유 의약 제제의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
JP4664815B2 (ja) * 2003-09-11 2011-04-06 ヒュービットジェノミクス株式会社 硬化をもたらす増殖性疾患の検出方法及びキット、硬化をもたらす増殖性疾患の予防及び／又は治療剤、ならびに硬化をもたらす増殖性疾患の予防及び／又は治療に有効な物質を同定する方法及びキット

Also Published As

Publication number Publication date
CN101522194B (zh) 2011-06-15
CN101522194A (zh) 2009-09-02
WO2008016171A1 (fr) 2008-02-07
JPWO2008016171A1 (ja) 2009-12-24

Similar Documents

Publication Publication Date Title
JP5968927B2 (ja) 高血圧と代謝症候群の治療に用いられる薬物組成物及びその応用
CN112423742B (zh) 使用阿克他利预防或治疗肾纤维化或肾脏疾病
KR20090035581A (ko) 신장 기능 장해 예방ㆍ치료제
AU6291696A (en) Method of treating renal disease using an ace inhibitor and an A II antagonist
JP2008044871A (ja) 心血管疾患予防・治療剤
US20190175551A1 (en) Medicine for treating renal disease
US8022086B2 (en) Therapeutic agent for glomerular disease
US6204271B1 (en) Analgesic composition and method for using same
JP2008063328A (ja) 糸球体疾患治療剤
Ogihara et al. Clinical efficacy and tolerability of candesartan cilexetil
JP4702054B2 (ja) 増強剤
JP4675586B2 (ja) 高血圧症及び血清高尿酸血症の重複発症の治療のための薬剤
EP1579872B1 (fr) Inhibiteur de prise de poids corporel
Hashimoto et al. A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats
DE69923982T2 (de) Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten
Murahata et al. Antagonistic effects of atipamezole, yohimbine, and prazosin on xylazine-induced diuresis in clinically normal cats
KR20230006884A (ko) 뇌 아미노펩티다제 a 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물
JP2006008549A5 (fr)
Kanno et al. Does combined therapy of Ca-channel blocker and angiotensin converting enzyme inhibitor exceed monotherapy in renal protection against hypertensive injury in rats?
CN117599062A (zh) 一种辅助改善记忆、预防或治疗阿尔茨海默病的组合物
CN110772523A (zh) 一种用于防治肾病的药物组合物
WO2013073382A1 (fr) Médicament pour le traitement ou la prévention d'une néphropathie
AU3534500A (en) Use of k-252a derivative for the treatment of peripheral or central nerve disorders, ...

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application